Overcome Chemoresistance: Biophysical and Structural Analysis of Synthetic FHIT-Derived Peptides.
FHIT
annexin A4
biophysical assay
chemoresistance
peptide
Journal
Frontiers in molecular biosciences
ISSN: 2296-889X
Titre abrégé: Front Mol Biosci
Pays: Switzerland
ID NLM: 101653173
Informations de publication
Date de publication:
2021
2021
Historique:
received:
26
05
2021
accepted:
07
10
2021
entrez:
13
12
2021
pubmed:
14
12
2021
medline:
14
12
2021
Statut:
epublish
Résumé
The fragile histidine triad (FHIT) protein is a member of the large and ubiquitous histidine triad (HIT) family of proteins. On the basis of genetic evidence, it has been postulated that the FHIT protein may function as tumor suppressor, implying a role for the FHIT protein in carcinogenesis. Recently, Gaudio et al. reported that FHIT binds and delocalizes annexin A4 (ANXA4) from plasma membrane to cytosol in paclitaxel-resistant lung cancer cells, thus restoring their chemosensitivity to the drug. They also identified the smallest protein sequence of the FHIT still interacting with ANXA4, ranging from position 7 to 13: QHLIKPS. This short sequence of FHIT protein was not only able to bind ANXA4 but also to hold its target in the cytosol during paclitaxel treatment, thus avoiding ANXA4 translocation to the inner side of the cell membrane. Starting from these results, to obtain much information about structure requirements involved in the interaction of the peptide mentioned above, we synthetized a panel of seven peptides through an Ala-scan approach. In detail, to study the binding of FHIT derived peptides with ANXA4, we applied a combination of different biophysical techniques such as differential scanning fluorimetry (DSF), surface plasmon resonance (SPR), and microscale thermophoresis (MST). Circular dichroism (CD) and nuclear magnetic resonance (NMR) were used to determine the conformational structure of the lead peptide (7-13) and peptides generated from ala-scan technique. The application of different biophysical and structural techniques, integrated by a preliminary biological evaluation, allowed us to build a solid structure activity relationship on the synthesized peptides.
Identifiants
pubmed: 34901149
doi: 10.3389/fmolb.2021.715263
pii: 715263
pmc: PMC8655160
doi:
Types de publication
Journal Article
Langues
eng
Pagination
715263Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2021 Scala, Di Micco, Lanzillotta, Musella, Di Sarno, Parrino, Casciofierro, Bifulco, Trapasso, Campiglia and Sala.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Protein Sci. 1996 Feb;5(2):212-20
pubmed: 8745398
Int J Cancer. 2014 Apr 15;134(8):1796-809
pubmed: 24150977
Oncotarget. 2014 Sep 15;5(17):7776-87
pubmed: 25277200
J Mol Biol. 1997 Oct 17;273(1):283-98
pubmed: 9367762
ACS Med Chem Lett. 2010 Feb 04;1(1):44-8
pubmed: 24900174
Nat Rev Mol Cell Biol. 2005 Jun;6(6):449-61
pubmed: 15928709
Int J Mol Sci. 2020 May 02;21(9):
pubmed: 32370233
J Biomol NMR. 1996 Dec;8(4):477-86
pubmed: 9008363
J Am Chem Soc. 2007 Mar 14;129(10):3007-12
pubmed: 17311384
Biochemistry. 2002 Jul 23;41(29):9003-14
pubmed: 12119013
Biochem Biophys Res Commun. 1983 Jun 29;113(3):967-74
pubmed: 6307308
Bioorg Med Chem. 2010 May 1;18(9):3252-60
pubmed: 20381359
Oncotarget. 2016 May 24;7(21):29927-36
pubmed: 27166255
ADMET DMPK. 2019 Dec 11;7(4):222-241
pubmed: 35359617
Mol Cancer. 2017 Dec 28;16(1):179
pubmed: 29282095
PLoS One. 2013 Nov 06;8(11):e78610
pubmed: 24223161
Eur J Med Chem. 2013 Nov;69:384-92
pubmed: 24077529
Cancers (Basel). 2014 Sep 05;6(3):1769-92
pubmed: 25198391
Arch Biochem Biophys. 1999 Jan 1;361(1):65-74
pubmed: 9882429
PLoS One. 2013 Nov 11;8(11):e80359
pubmed: 24244679
Sci Rep. 2017 Sep 6;7(1):10593
pubmed: 28878220
Bioorg Med Chem. 2008 Sep 15;16(18):8635-42
pubmed: 18715788
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W668-73
pubmed: 15215473
Science. 1997 Oct 10;278(5336):286-90
pubmed: 9323207
J Pathol. 2008 Oct;216(2):131-40
pubmed: 18698663